NSC |
Compound |
Enrichment |
Correlation |
NSC 633498 |
Null |
0.000104553642000969 |
0.6388128 |
NSC 639503 |
Cyclopentanone, 2-hexylidene-5-[(4-morpholinyl)methyl]-, hydrochloride |
0.000104553642000969 |
0.69094902 |
NSC 639512 |
Cyclopentanone, 2-[(4-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride |
0.000104553642000969 |
0.74993594 |
NSC 677697 |
7H-Pyrrolo[2,3-d]pyrimidine, 5,6-dimethyl- 2,4-bis(methylsulfinyl)-7-phenyl- |
0.000104553642000969 |
0.78682939 |
NSC 711745 |
Null |
0.000104553642000969 |
0.56247786 |
NSC 651081 |
1H-Pyrrolo[1,2-a]benzimidazole-5,8-dione, 6-(acetylamino)- 2,3-dihydro-3-hydroxy-7-methyl- |
0.000132595565954569 |
0.53040358 |
NSC 661224 |
Null |
0.000132595565954569 |
0.82606413 |
NSC 678636 |
Benzoic acid, 4-[[(3,6-dioxo-1,4-cyclohexadienyl)methyl]amino]-, benzyl ester |
0.000132595565954569 |
0.75832726 |
NSC 644916 |
ANTINEOPLASTIC-644916 |
0.000174252554411806 |
0.67565226 |
NSC 659999 |
Naphthalene-1,4-dione, 2-bromo-5,8-dihydroxy- 3-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]-, hydrochloride |
0.000174252554411806 |
0.68048854 |